Cytotheryx, Inc.

Cytotheryx, Inc. is a preclinical cell therapy company focused on the development of a readily available, consistent and high-quality source of primary human hepatocytes (liver cells) and the use of those cells for research and clinical applications, addressing unmet needs and improving lives globally. Cytotheryx has exclusive licenses to patented technology developed at Mayo Clinic for a bio-incubator that expands primary human hepatocytes.